Inhibition of sodium–glucose cotransporter-2 preserves cardiac function during regional myocardial ischemia independent of alterations in myocardial substrate utilization
- 19 April 2019
- journal article
- research article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 114 (3) , 1-13
Abstract
The goal of the present study was to evaluate the effects of SGLT2i on cardiac contractile function, substrate utilization, and efficiency before and during regional myocardial ischemia/reperfusion injury in normal, metabolically healthy swine. Lean swine received placebo or canagliflozin (300 mg PO) 24 h prior to and the morning of an invasive physiologic study protocol. Hemodynamic and cardiac function measurements were obtained at baseline, during a 30-min complete occlusion of the circumflex coronary artery, and during a 2-h reperfusion period. Blood pressure, heart rate, coronary flow, and myocardial oxygen consumption were unaffected by canagliflozin treatment. Ventricular volumes remained unchanged in controls throughout the protocol. At the onset of ischemia, canagliflozin produced acute large increases in left ventricular end-diastolic and systolic volumes which returned to baseline with reperfusion. Canagliflozin-mediated increases in end-diastolic volume were directly associated with increases in stroke volume and stroke work relative to controls during ischemia. Canagliflozin also increased cardiac work efficiency during ischemia relative to control swine. No differences in myocardial uptake of glucose, lactate, free fatty acids or ketones, were noted between treatment groups at any time. In separate experiments using a longer 60 min coronary occlusion followed by 2 h of reperfusion, canagliflozin increased end-diastolic volume and stroke volume and significantly diminished myocardial infarct size relative to control swine. These data demonstrate that SGLT2i with canagliflozin preserves cardiac contractile function and efficiency during regional myocardial ischemia and provides ischemia protection independent of alterations in myocardial substrate utilization.Keywords
Funding Information
- Eli Lilly and Company
This publication has 48 references indexed in Scilit:
- Mitochondria as a Therapeutic Target in Heart FailureJACC, 2013
- The in-situ pig heart with regional ischemia/reperfusion — Ready for translationJournal of Molecular and Cellular Cardiology, 2011
- Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family membersDiabetes Therapy, 2010
- Myocardial Substrate Metabolism in the Normal and Failing HeartPhysiological Reviews, 2005
- Defective calcium handling in cardiomyocytes isolated from hearts subjected to ischemia-reperfusionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Ca 2+ /Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine ReceptorCirculation Research, 2004
- Ventricular Function and Calcium Handling During IschemiaJournal of Cardiovascular Pharmacology, 1992
- Interrelations between coronary artery pressure, myocardial metabolism and coronary blood flowJournal of Molecular and Cellular Cardiology, 1990
- Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusionCardiovascular Research, 1987
- Effects of coronary artery reperfusion on regional myocardial blood flow and function in conscious baboons.Circulation, 1985